Skip navigation

Leadership Seminar – Clinical Genomics – From Exciting Technologies to Clinical Adoption

10:00 - 18:30

EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD
28 March 2018

With the rapid developments in genome sequencing technologies and the characterisation of expressed human genes, has emerged the exciting field of clinical genomics. Clinical genomics could revolutionize the way medicine is delivered by allowing (i) a better characterisation of diseases we currently don’t diagnose; (ii) earlier diagnostics of lethal conditions; and (iii) bring the concept of patient stratification in order to better understand risks and predict drug responses. But as with all successful revolutions this can’t happen in one day and the tremendous potential health benefits must be balanced with the many barriers to adoption in terms of adapting existing regulatory, reimbursement and care systems to accommodate adoption of these technologies.  

This event will review some areas in which clinical genomics can have a significant impact including rare diseases, infection diseases and cancer and will discuss how to ensure these technologies reach the widest patient audience possible.

It is aimed at anybody from academia or industry with an interest in genomics and its impact on healthcare delivery.


10.00 - Registration and welcome coffee / tea
10.30 - Welcome from One Nucleus and EBI
10.40 - Keynote presentations 
An academic and industry leader to set the scene of advancements and challenges in clinical genomics
Richard Capper, Illumina

11.30 - Clinical Genomics to Detect Pathogens
This session will showcase sequencing technologies applied to infectious diseases diagnostics. 

12.30 -

13.30 -
Clinical Genomics to Diagnose and Stratify

This stream will showcase technologies that use biomarkers to detect specific disorders (rare diseases, cancer) and to stratify patients for treatments. This will include, prenatal blood diagnostics, cancer signature and liquid biopsy.
Confirmed speaker: Prof Clive Morris, CMO of Inivata confirmed.

15.10 - Break

15.40 -
The route to market and clinical adoption 

This stream will allow discussion on how to make patients accessing these technologies. It will include NHS implementation, regulatory and market access
Confirmed speaker: Prof Joanne Hackett, Genomics England

17.00 - Closing keynote 

- Drinks reception

- Close

Gold Members - £75 + VAT 
Silver Members - £175 + VAT 
Non-member - £275 + VAT
Academics - £75 + VAT 

Please email to get your academic discount code 

Title: Leadership Seminar – Clinical Genomics – From Exciting Technologies to Clinical Adoption
Start: 2018-03-28 10:00:00Z
End: 2018-03-28 18:30:00Z